# CVD Risk Estimator Plus vs Pharmix فارمیکس

CVD Risk Estimator Plus and Pharmix فارمیکس both sit at 5.0 stars, but that hides the real split: 100% of Pharmix فارمیکس's written reviews are positive against 32% of CVD Risk Estimator Plus's. Pharmix فارمیکس also leads on update cadence (every 2 weeks vs every 4 months) and ratings volume (10 vs 1). On price, rating, ads and in-app purchases there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

On the App Store both sit at effectively the same score — 5.0 for CVD Risk Estimator Plus against 4.9 for Pharmix فارمیکس. That said, the two scores are not equally well evidenced: Pharmix فارمیکس has 10 ratings behind it against 1, so its average is the more settled of the two. Written reviews are what separate them: 32% of CVD Risk Estimator Plus's written reviews are positive against 100% of Pharmix فارمیکس's.

CVD Risk Estimator Plus ships an update every 4 months, Pharmix فارمیکس every 2 weeks. The most recent releases landed on October 17, 2026 and October 6, 2026 respectively.

## The numbers

| Metric | CVD Risk Estimator Plus | Pharmix فارمیکس |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[5.0 (1 ratings)](https://appshunter.io/ios/app/cvd-risk-estimator-plus/id808875968/reviews)** | [4.9 (10 ratings)](https://appshunter.io/ios/app/pharmix/id6766433870/reviews) |
| Number of ratings | 1 | **10** |
| Positive reviews | 31.6% of reviews | **100.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 4 months | **Every 2 weeks** |
| Monetization | Free | Free |
| Size | 59 MB | 51 MB |
| Requires iOS | 13.0 | 13.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 4+ |
| Developer | [American College of Cardiology](https://appshunter.io/developer/502174543) | [WeserMedic](https://appshunter.io/developer/1896289098) |

## What reviewers say

### CVD Risk Estimator Plus

[App page](https://appshunter.io/ios/app/cvd-risk-estimator-plus/id808875968)

This clinical decision support app provides comprehensive cardiovascular disease risk assessments for clinicians. It unifies two major risk calculators, incorporating traditional ASCVD modeling with modern kidney and metabolic health measures for personalized patient care.

**Highlights:** Combines ASCVD and PREVENT calculators, Calculates 10-year and lifetime CVD risk, Incorporates kidney and metabolic health, Provides risk category classification, Exports results for documentation, Includes clinician and patient resources

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Pharmix فارمیکس

[App page](https://appshunter.io/ios/app/pharmix/id6766433870)

This app allows users to browse and order medications from pharmacies. It simplifies the process of finding available products and completing purchases.

**Highlights:** Browse available pharmacy products, Add items to cart, Place medication orders, User-friendly interface

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is CVD Risk Estimator Plus free?

CVD Risk Estimator Plus is free to download, with no in-app purchases.

### Is Pharmix فارمیکس free?

Pharmix فارمیکس is free to download, with no in-app purchases.

### Which has better reviews, CVD Risk Estimator Plus or Pharmix فارمیکس?

CVD Risk Estimator Plus is rated higher. CVD Risk Estimator Plus averages 5.0 out of 5 from 1 ratings, while Pharmix فارمیکس averages 4.9 from 10 ratings.

### Do CVD Risk Estimator Plus or Pharmix فارمیکس have ads?

Neither CVD Risk Estimator Plus nor Pharmix فارمیکس shows ads.

### Which is updated more often, CVD Risk Estimator Plus or Pharmix فارمیکس?

CVD Risk Estimator Plus ships an update every 4 months, and Pharmix فارمیکس every 2 weeks. Most recently, CVD Risk Estimator Plus was updated on October 17, 2026 and Pharmix فارمیکس on October 6, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*